首页> 美国卫生研究院文献>Case Reports in Medicine >Anti-HPA-1b Mediated Posttransfusion Purpura: A Case Report
【2h】

Anti-HPA-1b Mediated Posttransfusion Purpura: A Case Report

机译:抗HPA-1b介导的输血后紫癜:一例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Posttransfusion purpura (PTP) is an uncommon, but potentially fatal, transfusion reaction characterized by profound thrombocytopenia and bleeding. PTP is caused by alloimmunization to human platelet specific antigens following blood component transfusion. Although there is evidence of a wide serological spectrum of culprit antibodies implicated, Anti-human-platelet-antigen- (HPA-) 1a is the most common antibody in cases reported. We report a case of posttransfusion purpura in an African American. The patient was negative for HPA-1a antibodies, but anti-HPA-1b was identified with a platelet phenotype of HPA-1a/HPA-1a. Although less common, HPA-1b antibody may be an important consideration in posttransfusion purpura diagnosed in patients of African descent.
机译:输血后紫癜(PTP)是一种罕见的但潜在的致命输血反应,其特征是严重的血小板减少和出血。 PTP是由血液成分输注后对人血小板特异性抗原的同种免疫引起的。尽管有证据表明所涉罪犯抗体的血清学谱范围很广,但在报告的病例中,抗人血小板抗原-(HPA-)1a是最常见的抗体。我们报告了一例非裔美国人的输血后紫癜。该患者的HPA-1a抗体阴性,但抗HPA-1b的血小板表型为HPA-1a / HPA-1a。尽管不常见,但是HPA-1b抗体可能是非洲人后裔诊断出的输血后紫癜的重要考虑因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号